- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04446195
The Effect of Individualized Intervention on the Quality of Bowel Preparation
The Effect of Individualized Intervention on the Quality of Intestinal Preparation: a Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710004
- The Second Affiliated Hospital of Xi'an Jiaotong University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- Aged between 18-75
- Patients with insufficient bowel preparation
- Patients without cognitive and communication barriers
- Informed consent, voluntary participation in the study Exclusion criteria:
1. Severe suppurative inflammation of anus and rectum 2. Severe acute enteritis and ischemic enteropathy 3. After partial colorectal resection 4. Peritonitis, intestinal perforation, extensive adhesion in the abdominal cavity and intestinal stenosis caused by various reasons 5. Large abdominal aneurysm, highly abnormal bowel flexion and late cancer with extensive intraperitoneal metastasis 6. Dysphagia or impaired swallowing reflex 7. Obvious gastroparesis or gastric outlet obstruction or intestinal obstruction 8. Severe chronic renal failure (creatinine clearance < 30 ml / min) 9. Severe congestive heart failure (NYHA class III or IV) 10. Uncontrolled hypertension (systolic pressure > 170 mm Hg, diastolic pressure > 100 mm Hg) 11. Toxic colitis or megacolon 12. Disorder of water and electrolyte 13. Pregnancy or lactation 14. Mental patients 15. Failure to give informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Control group
The control group received routine intestinal preparation education.
|
|
|
ACTIVE_COMPARATOR: Experimental group
The experimental group was treated with routine intestinal preparation education and individualized intervention.
|
In this study, patients with the risk factors of insufficient intestinal preparation were treated with individualized intervention (mainly from the following aspects: chronic constipation, intestinal preparation not strictly in accordance with the requirements, body mass index > 25 kg / m2, age > 70 years old, with other diseases such as diabetes, Parkinson's disease, history of stroke or spinal cord injury, etc., application of tricyclic antidepressants or anesthetics).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bowel preparation pass rate
Time Frame: During colonoscopy, endoscopists evaluated the quality of bowel preparation according to the Boston bowel preparation scale.
|
The Boston Bowel preparation scale ≥6 indicates qualified intestinal preparation.
|
During colonoscopy, endoscopists evaluated the quality of bowel preparation according to the Boston bowel preparation scale.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jinhai Wang, MD, The Second Affiliated Hospital of Xi'an Jiaotong University,Xi'an, Shanxi, China
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 20200618
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bowel Preparation Solutions
-
The Cleveland ClinicFerring PharmaceuticalsTerminated
-
St. Joseph's Healthcare HamiltonMcMaster UniversityUnknownEndoscopy | Bowel Preparation SolutionsCanada
-
Queen Elizabeth Hospital, Hong KongCompletedBowel Preparation Solutions | ColonoscopyHong Kong
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedBowel Preparation Solutions | Colonoscopy | InpatientItaly
-
Nanfang Hospital, Southern Medical UniversityRecruitingBowel Preparation Solutions | Colonoscopy | Colorectal Cancer ScreeningChina
-
Seoul National University Bundang HospitalCompletedBowel Preparation Solutions | Colonoscopy | Colon Polyp
-
American University of Beirut Medical CenterCompletedLaxative Bowel Cleansing Solutions
-
Universitaire Ziekenhuizen KU LeuvenNorgine BVActive, not recruitingHealthy | Bowel Preparation | Bowel Preparation for Colonoscopy | Bowel Cleansing for ColonoscopyBelgium
-
University of British ColumbiaCompletedEfficacy of Bowel Preparation | Ease of Bowel Preparation and Patient TolerabilityCanada
-
Alexandra Hospital, Athens, GreeceRecruitingBowel Preparation | Preparation for ColonoscopyGreece
Clinical Trials on Individualized Intervention
-
European University Miguel de CervantesCompletedChildren With Physical Disabilities | Adolescents With Physical DisabilitiesSpain
-
Miami UniversityNational Institute on Aging (NIA); Virginia Polytechnic Institute and State... and other collaboratorsCompletedDepression | Dementia | BehaviorUnited States
-
Anhui Provincial HospitalNot yet recruiting
-
The Hospital for Sick ChildrenCompleted
-
The Affiliated Hospital of Hangzhou Normal UniversityEnrolling by invitationPain | Irritable Bowel Syndrome (IBS) | Depressive Disorder, Major, ModerateChina
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Completed
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Luz A. Venta, MDCompletedBreast Cancer | Triple Negative Breast Cancer | Emotions | ImmunologyUnited States
-
University of SaskatchewanSaskatchewan Centre for Patient-Oriented Research; Saskatchewan Health Research...CompletedMultiple SclerosisCanada
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Completed